“Both companies are ‘houses of brands’, in other words a collection of well-diversified luxury businesses serving multiple ...

Amylyx Pharmaceuticals has named Dan Monahan as chief commercial officer, positioning an exec who led the U.S.

Among the FDA’s pending decisions for this quarter are Vertex’s non-opioid pain drug and Sanofi’s RNA interference therapy ...

Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced the appointment of Dan Monahan as Chief Commercial Officer. Mr. Monahan will also join the Company’s Leadership ...

I-Mab has begun the new year with a pipeline pivot, pausing work on an asset that Sanofi bought into last year to focus on ...

For animals, 2024 was full of milestones that stopped suffering and saved lives. More people have realized that every animal is someone with a right to be treated with kindness and respect.

The U.S. continues to charge significantly higher prices for prescription drugs compared with similarly wealthy countries.

Researchers design a new way to more reliably evaluate AI models' ability to make clinical decisions in realistic scenarios that closely mimic real-life interactions. The analysis finds that ...

A Florida-based car dealer has joined mounting litigation against Eli Lilly, Novo Nordisk and Sanofi over what it calls the “exorbitant” price of insulin.

Hemophilia News Today compiled a summary of the 10 most read hemophilia stories of 2024, with links to the individual items.

Share prices of Aurora Innovation dropped for a fourth consecutive day on Thursday as investors continued to sell off ...

In separate DLL3 antibody-drug conjugate (ADC) deals, Roche licensed from Innovent Biologics and Ideaya reached for Hengrui.